Serum- kalium bør overvåges i behandlingsforløbet, idet den renale udskillelse af phenylacetylglutamin kan fremkalde tab af kalium via urinen.
Serum potassium should be monitored during therapy since renal excretion of phenylacetylglutamine may induce a urinary loss of potassium.